11
results
for author:"Zuo D."
in Literature Citations
| Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Ponzo M.G., Lesurf R., Petkiewicz S., O'Malley F.P., Pinnaduwage D., Andrulis I.L., Bull S.B., Chughtai N., Zuo D., Souleimanova M. et al. Proc. Natl. Acad. Sci. U.S.A. 106:12903-12908(2009) · Mapped (32) |
| Influence of basic fibroblast growth factor on the growth of HeLa cells and the expression of angiogenin. Yang J., Wang J., Zhao J., Zuo D., Li X., Wang L. Oncol. Rep. 21:949-955(2009) · Mapped (5) |
| ShcA signalling is essential for tumour progression in mouse models of human breast cancer. Ursini-Siegel J., Hardy W.R., Zuo D., Lam S.H., Sanguin-Gendreau V., Cardiff R.D., Pawson T., Muller W.J. EMBO J. 27:910-920(2008) · Mapped (1) |
| Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Lahlou H., Sanguin-Gendreau V., Zuo D., Cardiff R.D., McLean G.W., Frame M.C., Muller W.J. Proc. Natl. Acad. Sci. U.S.A. 104:20302-20307(2007) · Mapped (1) |
| Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development. Ursini-Siegel J., Rajput A.B., Lu H., Sanguin-Gendreau V., Zuo D., Papavasiliou V., Lavoie C., Turpin J., Cianflone K., Huntsman D.G. et al. Mol. Cell. Biol. 27:6361-6371(2007) · Mapped (1) |
| Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F., Camargo A.A., Kelley F., McCarron S., Jepson D. et al. Genome Res. 17:536-543(2007) · UniProtKB (1,727) |
| Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. Long J., Zuo D., Park M. J. Biol. Chem. 280:35477-35489(2005) · UniProtKB (4) · Mapped (15) |
| Expression of human CGT52TGT MBL mutant in CHO cells and analysis of the expression product. Liu F.L., Zuo D.M., Bai Z.J., Chen Z.L. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 21:399-402(2005) · Mapped (3) |
| CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Rodrigues S.P., Fathers K.E., Chan G., Zuo D., Halwani F., Meterissian S., Park M. Mol. Cancer Res. 3:183-194(2005) · Mapped (3) |
| Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., Muller W.J. Cancer Cell 6:159-170(2004) · Mapped (5) |
| Modulation of protein translation by Nck-1. Kebache S., Zuo D., Chevet E., Larose L. Proc. Natl. Acad. Sci. U.S.A. 99:5406-5411(2002) · Mapped (10) |
